RE: Iceman23 May 2024 08:42
One of the main reasons the Telegram group wanted a shareholder on the board was to ensure TRx wasn't wasting our time. We needed to validate the Val 201 deal and, if TRx couldn't raise funds or were not making meaningful progress, to drop them and move on. We felt that shareholders were too focused on Val 201 and were not appreciating the progress on other drugs . Kings and Val 401 are doing really well, and the professor mentioned that Kings could be worth many times more than Val 201.
For me, this update is a validation that things are going well. I see no reason not to buy more and keep building my position. When the news comes it will be too late to buy.
Anyway, it feels really good to finally have someone on the board who speaks up for shareholders. I personally feel very relaxed, and I think regular RNS updates will rebuild confidence in this company. So, I'm happy to wait and let this play out.
GLA!